They will join the Executive Committee, bolstering the company’s strategic leadership.
3PBIOVIAN is pleased to announce the appointment of three distinguished professionals to its executive team: Jorge García as Site Head, Miguel Mansilla as Director of Compliance, and Alejandro Mateo as Director of Quality Assurance.
Jorge García, the new Site Head, holds a degree and a PhD in Biology from the Autonomous University of Madrid, with extensive experience in the health sector, including roles at companies such as Serono, Merck, and Polpharma Biologics. Most recently, he served as Technical Operations Director and Site Head of Polpharma’s Duchnice (Poland) plant. Jorge joins 3PBIOVIAN to lead operations at the Pamplona site.
Miguel Mansilla, the new Director of Compliance, holds a degree in Chemistry with a specialization in Chemical Engineering. With vast experience in the biotechnology sector, Miguel has held key positions at Chemo and InsudPharma, most recently serving as Head of Quality Assurance at Alcaliber. His appointment will strengthen the company’s compliance function.
Alejandro Mateo joins as Director of Quality Assurance (QA). He holds a degree in Biochemistry from the University of Bath (UK) and has an outstanding track record in the biotechnology sector, having worked at companies such as Wuxi Vaccines, Uniqure, Lonza, and Boehringer Ingelheim. Alejandro will bring his experience in international quality management, enhancing 3PBIOVIAN’s leadership in this area.
Dámaso Molero, CEO of 3PBIOVIAN, comments: “We are delighted to welcome Jorge, Miguel, and Alejandro. Each of them brings valuable experience that will be key to our continued growth and to strengthening our position as one of the leading CDMOs in Europe.” With these appointments, 3PBIOVIAN strengthens its competitive position in the European market and reaffirms its commitment to excellence in the development and manufacturing of biotechnology products.